Keywords: Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 2 DE; 2-dimensional electrophoresis; ABPP; activity-based protein profiling; BFGF; basic fibroblast growth factor; CML; chronic myeloid leukemia; CRC; colorectal cancer; DIGE; differential in gel electrophoresis; EGF(R); epidermal growth factor (receptor)
Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice
Keywords: Hepatic cell sheets; Mesenchymal stem cells; Liver regeneration; Wnt/β-catenin signal inhibitor; Acute liver failure; BM-MSCs; bone marrow-derived mesenchymal stem cells; NF-κB; nuclear factor-kappa B; IL-6; interleukin-6; STAT-3; Signal Tranducer and A
Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET
Keywords: INPPL1; HGFR; SH2 domain; Solution NMR structure; Tyrosine phosphorylation;
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
Keywords: Cancer targeted therapy; Met; Antibody; Fab; Half-life; Protein engineering; HGF; hepatocyte growth factor; HGFR; hepatocyte growth factor receptor; EGFR; epidermal growth factor receptor; mAb; monoclonal antibody; MvDN30; monovalent chimerized DN30 Fab;
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
Keywords: CVD; cardiovascular disease; CHF; congestive heart failure; ctrl; control; DOX; doxycycline; ECM; Extracellular Matrix; LV; lentiviral; HFpEF; heart failure with preserved ejection function; Hgf; hepatocyte growth factor; HCM; hypertrophic cardiomyopathy;
Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway
Keywords: GM3; Metastasis; EGFR; HGFR; Akt; CD82/KAI-1;
Growth factors expression in patients with erosive esophagitis
Keywords: bFGF; basic fibroblast growth factor; COX; cyclooxygenase; EE; erosive esophagitis; EGF; epidermal growth factor; EGFR; EGF receptor; ERK; extracellular signal regulated kinase; GERD; gastroesophageal reflux disease; HGF; hepatocyte growth factor; HGFR; H
Extent of over-expression of hepatocyte growth factor receptor in colorectal tumours is dependent on the choice of normaliser
Keywords: Quantitative real-time RT-PCR; Reference gene; Normalisation; 2-ΔΔCT2-ΔΔCT method; HGFR; Colorectal tumours; Over-expression